Alector, Inc.(ALEC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,908 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
ALEC Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Alector, Inc. (ALEC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ALEC at 10.9/100 on a 32-signal composite quality model, placing it at rank #2,908 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include free cash flow (4.2) and balance sheet strength (4.6), which score below median versus the broader universe. Shareholder dilution risk is elevated at 2.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Alector, Inc. reports quarterly revenue of $3.3M, net income of $-23.0M, free cash flow of $-34.2M. Top institutional holders of ALEC by reported 13-F value include TCG Crossover Management, BlackRock, ACADIAN ASSET MANAGEMENT, based on the most recent SEC filings. ALEC trades on the Nasdaq exchange and files with the SEC under CIK 1653087. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ALEC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Alector, Inc. directly from SEC EDGAR. Alector, Inc.'s 13F Pro composite quality score has ranged between 6 and 72 since 2021, currently 10.9 — a stable long-term trajectory across 68 quarterly and live scoring snapshots.
Revenue
Q2 2026
$3.3M
Net Income
Q2 2026
$-23.0M
Free Cash Flow
Q2 2026
$-34.2M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-79.1% YoYNet Income
-20.1% YoYOperating Income
-7.6% YoYEPS (Diluted)
-13.0% YoYTotal Assets
-37.4% YoYTotal Debt
+7.3% YoYOp. Cash Flow
+20.0% YoYFree Cash Flow
+20.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $21.0M -79.1% | $100.6M +3.6% | $97.1M -27.3% | $133.6M -35.5% | $207.1M +881.5% | $21.1M |
| Net Income | $-142.9M -20.1% | $-119.0M +8.7% | $-130.4M +2.2% | $-133.3M -267.0% | $-36.3M +80.9% | $-190.2M |
| Operating Income | $-156.0M -7.6% | $-145.0M +4.4% | $-151.7M -10.1% | $-137.8M -268.9% | $-37.4M +80.9% | $-195.2M |
| EPS (Diluted) | $-1.39 -13.0% | $-1.23 +21.2% | $-1.56 +3.7% | $-1.62 -260.0% | $-0.45 +81.6% | $-2.45 |
| Total Assets | $293.2M -37.4% | $468.3M -24.7% | $621.8M -21.1% | $787.6M -3.3% | $814.7M +66.9% | $488.3M |
| Total Debt | $10.7M +7.3% | $10.0M | $0.00 | — | — | — |
| Operating Cash Flow | $-184.0M +20.0% | $-229.9M -24.8% | $-184.2M -805.9% | $-20.3M -106.8% | $298.6M +279.1% | $-166.7M |
| Free Cash Flow | $-184.1M +20.4% | $-231.2M -23.9% | $-186.5M -663.1% | $-24.4M -108.3% | $295.3M +271.9% | $-171.8M |
Get alerted when ALEC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Alector, Inc. including:
Top Institutional Holders of ALEC
TCG Crossover Management, LLC
$20.1M10,000,000 shBlackRock, Inc.
$15.8M7,847,879 shACADIAN ASSET MANAGEMENT LLC
$8.9M4,414,345 shNantahala Capital Management, LLC
$8.7M4,318,109 shVANGUARD CAPITAL MANAGEMENT LLC
$8.1M4,009,340 shKynam Capital Management, LP
$7.7M3,808,494 shMerck & Co., Inc.
$7.1M3,545,719 shBALYASNY ASSET MANAGEMENT L.P.
$6.5M3,247,426 sh683 Capital Management, LLC
$6.4M3,200,000 shD. E. Shaw & Co., Inc.
$5.9M2,959,983 sh
| Fund | Value | Shares |
|---|---|---|
| TCG Crossover Management, LLC | $20.1M | 10,000,000 |
| BlackRock, Inc. | $15.8M | 7,847,879 |
| ACADIAN ASSET MANAGEMENT LLC | $8.9M | 4,414,345 |
| Nantahala Capital Management, LLC | $8.7M | 4,318,109 |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.1M | 4,009,340 |
| Kynam Capital Management, LP | $7.7M | 3,808,494 |
| Merck & Co., Inc. | $7.1M | 3,545,719 |
| BALYASNY ASSET MANAGEMENT L.P. | $6.5M | 3,247,426 |
| 683 Capital Management, LLC | $6.4M | 3,200,000 |
| D. E. Shaw & Co., Inc. | $5.9M | 2,959,983 |
Companies Similar to ALEC
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Entrada Therapeutics, Inc.
SUTRO BIOPHARMA, INC.
Silence Therapeutics plc
Nurix Therapeutics, Inc.
Equillium, Inc.
ENANTA PHARMACEUTICALS INC
Personalis, Inc.
CytomX Therapeutics, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put ALEC on your watchlist
Track score changes the day Alector, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ALEC a good stock to buy?
13F Pro's AI-powered analysis of Alector, Inc. (ALEC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ALEC are available on the ALEC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ALEC is classified as a small company.
Which hedge funds own ALEC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ALEC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Alector, Inc.'s investment landscape.